Key statistics
On Friday, NovaBay Pharmaceuticals Inc (B9P0:DEU) closed at 0.788, 126.44% above the 52 week low of 0.348 set on Aug 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.4365 |
---|---|
High | 0.788 |
Low | 0.4365 |
Bid | 0.637 |
Offer | 0.682 |
Previous close | 0.4365 |
Average volume | 400.00 |
---|---|
Shares outstanding | 4.89m |
Free float | 4.89m |
P/E (TTM) | -- |
Market cap | 3.62m USD |
EPS (TTM) | -65.73 USD |
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Press releases
- NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
- NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
- NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
- NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales
- NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option
- NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering
- NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day
- NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million
- NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities
- NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions
More ▼